ArticleNature communications2023

ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia.

Jessica Ebner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.